Advertisement
U.S. Markets close in 2 hrs 11 mins

Evogene Ltd. (EVGN.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA (0.01 ILS)
704.40-5.50 (-0.77%)
At close: 05:24PM IST

Evogene Ltd.

13 Gad Feinstein Street
Park Rehovot
Rehovot 7638517
Israel
972 8 931 1900
https://www.evogene.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees142

Key Executives

NameTitlePayExercisedYear Born
Mr. Ofer Haviv CPACEO & President390kN/A1966
Dr. Brian EmberChief Executive Officer of AgPlenus Ltd287kN/A1976
Dr. Elran Hillel Haber M.B.A., Ph.D.Chief Executive Officer of Biomica Ltd302kN/A1980
Mr. Amit Noam Capt. res.Chief Executive Officer of Lavie Bio Ltd.136kN/A1982
Mr. Yaron EldadChief Financial OfficerN/AN/A1965
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.

Description

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Corporate Governance

Evogene Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.